Impact of the HIV infection on the evolution of tuberculosis among adult patient in Yaounde, Cameroon;Impact de l'infection à VIH sur l'évolution de la tuberculose de l'adulte à Yaoundé, Cameroun

Revue de Pneumologie Clinique

Volumn 68, Issue 6, 2012, Pages 338-344

  Yone, E W P ^a,b   Kuaban, C ^a,b   Kengne, A P ^c  

^a Universite de Yaounde I Faculte de Medecine   (Cameroon)

^b Hopital Jamot   (Cameroon)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antituberculosis treatment; HIV infection; Outcome; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE;

ADULT; AGE DISTRIBUTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CAMEROON; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION PREVENTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMEAR; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CAMEROON; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 84870751723     PISSN: 07618417     EISSN: 17762561     Source Type: Journal    
DOI: 10.1016/j.pneumo.2012.10.001     Document Type: Article

References (30)

1. WHO report. Global tuberculosis control 2010. Téléchargé le 26 juin 2011. http://whqlibdoc.who.int/publications/2010/.
2. Mariani F., Goletti D., Ciaramella A., Martino A., Colizzi V., Fraziano M. Macrophage response to Mycobacterium tuberculosis during HIV infection: relationships between macrophage activation and apoptosis. Curr Mol Med 2001, 1:209-216.
3. Rosas-Taraco A.G., Arce-Mendoza A.Y., Caballero-Olín G., Salinas-Carmona M.C. Mycobacterium tuberculosis upregulates coreceptors CCR5 and CXCR4 while HIV modulates CD14 favoring concurrent infection. AIDS Res Hum Retroviruses 2006, 22:45-51.
4. Maartens G., Wilkinson R.J. Tuberculosis. Lancet 2007, 370:2030-2043.
5. Kuaban C., Bercion R., Koulla-Shiro S. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti tuberculosis treatment in Yaounde, Cameroon. East Afr Med J 1997, 74:474-477.
6. Kuaban C., Bame R., Mouangue L., Djella S., Yomgni C. Non conversion of sputum smears in new smear positive pulmonary tuberculosis patients in Yaoundé, Cameroon. East Afr Med J 2009, 86:219-225.
7. Sume G.E., Etogo D., Kabore S., Gnigninanjouena O., Epome S.S., Metchendje J.N. Seroprevalence of human immunodeficiency virus infection among tuberculosis patients in the Nylon district hospital tuberculosis treatment centre. East Afr Med J 2008, 85:529-536.
8. Adjei A.A., Adiku T.K., Ayeh-Kumi P.F., Hesse I.F. Prevalence of human immunodeficiency virus infection among tuberculosis suspect patients in Accra, Ghana. West Afr J Med 2006, 25:38-41.
9. Dagnra A.Y., Adjoh K., Tchaptchet Heunda S., Patassi A.A., Sadzo Hetsu D., Awokou F., et al. Prévalence de la co-infection VIH-tuberculose et impact de l'infection VIH sur l'évolution de la tuberculose pulmonaire au Togo. Bull Soc Pathol Exot 2010, 10.1007/s13149-010-0079-3.
10. e éd.) 2010, Union Internationale Contre la Tuberculose et les Maladies Respiratorires, Paris.
11. Programme National de Lutte contre la Tuberculose. Guide Technique pour le personnel de santé (2e éd. révisée). Ministère de la Santé Publique du Cameroun, Yaoundé, 2004.
12. Organisation Mondiale de la Santé. Le traitement de la tuberculose: Principes à l'intention des programmes nationaux. 3e éd. Organisation mondiale de la Santé-Genève 2003, WHO/CDS/TB 2003.313.
13. Zellweger J.P., Coulon P. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998, 2:372-377.
14. Corbett E.L., Marston B., Churchyard G.J., De Cock K.M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006, 367:926-937.
15. Ige O.M., Sogaolu O.M., Ogunlade O.A. Pattern of presentation of tuberculosis and the hospital prevalence of tuberculosis and HIV co-infection in University College Hospital, Ibadan, a review of five years (1998-2002). Afr J Med Sci 2005, 34:329-333.
16. Maher D., Harries A., Getahun H. Tuberculosis and HIV interaction in Sub-Saharan Africa: impact on patients and programmes, implications for policies. Trop Med Int Health 2005, 10:734-742.
17. Nkoghe D., Toung Mve M., Nnegue S., Okome Nkoume M., Iba B.J., Hypolite J., et al. Séroprévalence du VIH au sein des tuberculeux de l'hôpital de Nkembo à Libreville, Gabon. Bull Soc Pathol Exot 2005, 98:121-122.
18. Ollé-Goig J.E. Tuberculosis in rural Uganda. Afr Health Sci 2010, 10:226-229.
19. Habib A.G. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults. Ann Afr Med 2009, 8:147-155.
20. Cain K.P., Kanara N., Laserson K.F., Vannarith C., Sameourn K., Samnang K., et al. The epidemiology of HIV-associated tuberculosis in rural Cambodia. Int J Tuberc Lung Dis 2007, 11:1008-1013.
21. Pontororing G.J., Kenangalem E., Lolong D.B., Waramori G., Sandjaja, Tjitra E., et al. The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study. BMC Infect Dis 2010, 24:362.
22. AIDS epidemic update. UNAIDS/WHO 2008, available from: URL:. Downloaded on 15th of May, 2011. http://data.unaids.org/pub/Report/2008/jc%201535_annual_report07_fr.pdf.
23. Report on HIV sentinel surveillance system in Cameroon. Ministry of Public Health Yaoundé, Cameroon, 1994.
24. Sharma S.K., Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004, 120:316-353.
25. Golden M.P., Vikram H.R. Extrapulmonary tuberculosis: an overview. Am Fam Physician 2005, 72:176-178.
26. Aderaye G., Bruchfeld J., Assefa G., Feleke D., Källenius G., Baat M., et al. The relationship between disease pattern and disease burden by chest radiography. M. tuberculosis load, and HIV status in patients with pulmonary tuberculosis in Addis Ababa. Infection 2004, 32:333-338.
27. Mugusi F., Villamor E., Urassa W., Saathoff E., Bosch R.J., Fawzi W.W. HIV co-infection CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. Int J Tuberc Lung Dis 2006, 10:663-669.
28. Mukadi Y.D., Maher D., Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001, 15:143-152.
29. Abdool Karim S.S., Naidoo K., Grobler A., Padayatchi N., Baxter C., Gray A., et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010, 362:697-706.
30. Velasco M., Castilla V., Sanz J., Gaspar G., Condes E., Barros C., et al. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immun defic Syndr 2009, 50:148-152.